Noncoding RNAs in Cardiac Hypertrophy and Heart Failure

Cells. 2022 Feb 23;11(5):777. doi: 10.3390/cells11050777.

Abstract

Heart failure is a major global health concern. Noncoding RNAs (ncRNAs) are involved in physiological processes and in the pathogenesis of various diseases, including heart failure. ncRNAs have emerged as critical components of transcriptional regulatory pathways that govern cardiac development, stress response, signaling, and remodeling in cardiac pathology. Recently, studies of ncRNAs in cardiovascular disease have achieved significant development. Here, we discuss the roles of ncRNAs, including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs) that modulate the cardiac hypertrophy and heart failure.

Keywords: cardiac hypertrophy; heart failure; noncoding RNAs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiomegaly / genetics
  • Heart Failure* / genetics
  • Heart Failure* / metabolism
  • Humans
  • RNA, Circular / genetics
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism
  • RNA, Untranslated / genetics
  • RNA, Untranslated / metabolism

Substances

  • RNA, Circular
  • RNA, Long Noncoding
  • RNA, Untranslated